[en] The development of blood vessels inside tumors is required to provide the nutrients and
oxygen needed for tumor growth and to allow the spread of cancer cells at a distance to form metastasis. Angiogenesis is also implicated in ocular diseases like age-related macular degeneration. The present work describes the potential anti-angiogenic properties of a coumarinic derivative, 3-bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate (IK9), previously described as a potent inhibitor of HT 1080 fibrosarcoma cell invasion in vitro and tumor growth in vivo. In vivo, ex vivo, and in vitro models were used to delineate the anti-angiogenic properties of IK9. The anti-angiogenic effect of IK9 was demonstrated in vivo in a choroidal neovascularization mice model and additionally ex vivo in a rat aortic ring assay where it was more active than the known matrix metalloproteinase inhibitor Ro 28-2653. IK9 did
not affect apoptosis, proliferation, or endothelial cell invasiveness in vitro. These findings suggest a complex mechanism of action of the compound via direct or indirect effects on endothelial cell properties. This study identifies IK9 as a new potent inhibitor of angiogenesis and suggests its potential use as a therapeutic agent.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Hemmer, M.
Kempen, Isabelle
De Tullio, Pascal ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Blacher, Silvia ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Bueb, Jean-Luc
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Tschirhart, Eric
Pirotte, Bernard ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Language :
English
Title :
New Biological Investigations on 3-Bromophenyl 6-Acetoxymethyl-2-oxo-2H-1-Benzopyran-3-Carboxylate as Anti-angiogenic Agent
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Alfano RW, Leppla SH, Liu S, Bugge TH, Duesbery NS, Frankel AE. 2008. Potent inhibition of tumor angiogenesis by the matrix metalloproteinase- activated anthrax lethal toxin: implications for broad anti-tumor efficacy. Cell Cycle 7:745-749.
Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276-1312.
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
Berndt S, Bruyère F, Jost M, Noël A. 2008. In vitro and in vivo models of angiogenesis to dissect MMP functions. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF, editors. The cancer degradome-proteases and cancer biology. New York: Springer. p 305-325.
Blacher S, Devy L, Burbridge MF, Roland G, Tucker G, Noël A, Foidart JM. 2001. Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4:133-142. (Pubitemid 34032699)
Bruyère F, Noël A. 2009. Lymphangiogenesis: in vitro and in vivo models. FASEB J 24:8-21.
Carmeliet P. 2005. Angiogenesis in life, disease and medicine. Nature 438:932-936.
Daniewski AR, Liu W, Okabe M. 2004. An improved synthesis of the selective matrix metalloproteinase inhibitor, Ro 28-2653. Org Proc Res Dev 8:411-414. (Pubitemid 38829038)
Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, et al. 2002. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J 16:147-154. (Pubitemid 34113008)
Folkman J. 1971. Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186.
Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
Gerhardt H, Betsholtz C. 2003. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15-23.
Gupta GP, Massague J. 2006. Cancer metastasis: building a framework. Cell 127:679-695.
Han S, Zhou V, Pan S, Liu Y, Hornsby M, McMullan D, Klock HE, Haugen J, Lesley SA, Gray N, et al. 2005. Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors. Bioorg Med Chem Lett 15:5467-5473. (Pubitemid 41562972)
Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364. (Pubitemid 26272076)
Joseph IB, Vukanovic J, Isaacs JT. 1996. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. Cancer Res 56:3404-3408. (Pubitemid 26251627)
Jost M, Maillard C, Lecomte J, Lambert V, Tjwa M, Blaise P, Alvarez Gonzalez ML, Bajou K, Blacher S, Motte P, et al. 2007. Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. Am J Pathol 171:1369-1380. (Pubitemid 47582909)
Kalluri R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422-433. (Pubitemid 37328846)
Kempen I, Hemmer M, Counerotte S, Pochet L, de Tullio P, Foidart JM, Blacher S, Noël A, Frankenne F, Pirotte B. 2008. 6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis. Eur J Med Chem 43:2735-2750.
Kempen I, Papapostolou D, Thierry N, Pochet L, Counerotte S, Masereel B, Foidart JM, Reboud-Ravaux M, Noël A, Pirotte B. 2003. 3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo. Br J Cancer 88:1111-1118. (Pubitemid 36560785)
Lambert V, Munaut C, Noël A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM, Rakic JM. 2001. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J 15:1021-1027. (Pubitemid 32290790)
Maquoi E, Sounni NE, Devy L, Olivier F, Frankenne F, Krell HW, Grams F, Foidart JM, Noël A. 2004. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clin Cancer Res 10:4038-4047. (Pubitemid 38812479)
Mazzocca A, Carloni V. 2009. The metastatic process: methodological advances and pharmacological challenges. Curr Med Chem 16:1704-1717.
Nicosia RF, Ottinetti A. 1990a. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122.
Nicosia RF, Ottinetti A. 1990b. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 26:119-128.
Noël A, Jost M, Lambert V, Lecomte J, Rakic JM. 2007. Antiangiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends Mol Med 13:345-352.
Ostman A. 2004. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15:275-286.
Pan R, Dai Y, Yang J, Li Y, Yao X, Xia Y. 2009. Anti-angiogenic potential of scopoletin is associated with the inhibition of ERK1/2 activation. Drug Dev Res 70:214-219.
Pochet L, Doucet C, Schynts M, Thierry N, Boggetto N, Pirotte B, Jiang KY, Masereel B, de Tullio P, Delarge J, et al. 1996. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity. J Med Chem 39:2579-2585.
Pochet L, Doucet C, Dive G, Wouters J, Masereel B, Reboud-Ravaux M, Pirotte B. 2000. Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase. Bioorg Med Chem 8:1489-1501.
Rundhaug JE. 2005. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9:267-285.
Sengupta N, Caballero S, Mames RN, Butler JM, Scott EW, Grant MB. 2003. The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci 44:4908-4913. (Pubitemid 37315308)
Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK. 2003. Structure-activity relationships studies of the anti-angiogenic activities of linomide. Bioorg Med Chem Lett 13:1187-1189.
Shibuya M. 2001. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26:25-35. (Pubitemid 32421949)
Tomita M, Yamada H, Adachi Y, Cui Y, Yamada E, Higuchi A, Minamino K, Suzuki Y, Matsumura M, Ikehara S. 2004. Choroidal neovascularization is provided by bone marrow cells. Stem Cells 22:21-26. (Pubitemid 38018778)
Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B, Isaacs JT. 1993. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res 53:1833-1837.
Zetter BR. 1998. Angiogenesis and tumor metastasis. Annu Rev Med 49:407-424.
Zhong H, Bowen JP. 2006. Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 13:849-862.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
